AAV4Cancer
Terapias Avanzadas para Enfermedades Hepáticas Raras
Dissertationen geleitet (9) Dissertationen, die von den Mitgliedern der Gruppe geleitet wurden
2024
-
Advances in precision and safety of crispr-based gene targeting for primary hyperoxaluria type 1
Torella, Laura
unter der Leitung von Gloria González Aseguinolaza y Nerea Zabaleta Lasarte
2022
-
Development of new strategies for the modulation of the immune response against gene therapy vectors
ROS GAÑÁN, IRENE
unter der Leitung von Mirja Hommel y Gloria González Aseguinolaza
2021
-
Elucidating the mechanisms involved in liver damage and hepatitis B virus inhibition by hepatitis delta virus infection
Camps Ramón, Gracián
unter der Leitung von Rafael Aldabe Arregui y Gloria González Aseguinolaza -
Elucidating the mechanisms involved in HDV-induced pathogenesis
Maestro Galilea, Sheila
unter der Leitung von Gloria González Aseguinolaza y Rafael Aldabe Arregui -
Characterization of a Wilson Disease mouse model and development of novel therapies
Barberia Urteaga, Miren
unter der Leitung von Oihana Murillo Sauca y Gloria González Aseguinolaza
2019
-
Characterization of new strategies to overcome the barrier of neutralizing antibodies in the aav-based gene therapy
Salas Gómez, David
unter der Leitung von Gloria González Aseguinolaza -
Glucocerebrosidase gene therapy in animal models of Parkinson Disease
Sucunza, Diego
unter der Leitung von José Luis Lanciego Pérez y Gloria González Aseguinolaza
2018
-
Development of advanced genetic therapies for primary hyperoxaluria tipe I
Zabaleta Lasarte, Nerea
unter der Leitung von Gloria González Aseguinolaza y Juan Roberto Rodríguez Madoz -
Characterization of a mouse model for the study of hepatitis delta virus infection
Usai, Carla
unter der Leitung von Gloria González Aseguinolaza y Rafael Aldabe Arregui